SARS-CoV-2 seroprevalence in pregnant women in Kilifi, Kenya from March 2020 to March 2022. (2023)
Attributed to:
Immunomodulation and Vaccines
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fpubh.2023.1292932
PubMed Identifier: 38169905
Publication URI: http://europepmc.org/abstract/MED/38169905
Type: Journal Article/Review
Volume: 11
Parent Publication: Frontiers in public health
ISSN: 2296-2565